ArticleFrontiers in cellular and infection microbiology2026
Global, regional, and national burden of bone and joint infections, 1990-2021: a comprehensive analysis of trends, pathogens, and antimicrobial resistance.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bone and joint infections (BJIs) are disabling conditions whose global burden is evolving. This study aimed to systematically analyze the disease burden, temporal trends, pathogen spectrum, and resistance profiles of BJIs at the global, regional, and national levels from 1990 to 2021. Methods: Based on the Global Research on Antimicrobial Resistance Project, this study extracted data on deaths and disability-adjusted life years (DALYs) attributable to BJIs from 1990 to 2021, stratified by sex, age, region, pathogen, and antimicrobial resistance. Trends and inequalities were analyzed using estimated annual percentage change, the Bayesian age-period-cohort model and health inequality analysis. Results: Between 1990 and 2021, the global number of deaths due to BJIs increased by 228% (from 7,475 to 24,505), and DALYs increased by 291% (from 1,549,957 to 6,054,611), with age-standardized rates showing a consistent upward trend. The disease burden exhibited significant geographical inequality, with East Asia bearing the heaviest and fastest-growing burden. Conclusions: The global burden of BJIs continues to increase, exhibits significant regional inequalities, and antimicrobial resistance serves as a critical driver of health loss. These findings necessitate strengthened infection prevention and control, prudent antimicrobial use, and the development of novel therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.